SPARC announces submission of IND application for SBO-154 to USFDA
SBO-154 set to enter global Phase 1 clinical trial for treatment of advanced solid tumours
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
solid tumours
Cell therapy for solid tumors may get approval by 2022: GlobalData
A total of 298 industry-sponsored trials are currently ongoing investigating cell therapies in non-haematological cancers, says…
Bayer, Atara Biotherapeutics to partner for mesothelin-targeted CAR T-cell therapies
The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version,…
Rozlytrek from Roche gets EC approval to treat solid tumours and NSCLC
The approval is based on results from the integrated analysis of the pivotal phase II STARTRK-2, phase I STARTRK-1 and phase I…